SK
Sangita Kumari
About Sangita Kumari
Data last updated:
Sangita Kumari is a Director at Medvey Biotech Private Limited (since 2021) and Director at Astragenics Biosciences Private Limited (since 2025). The companies operate in Chemicals and Materials and Healthcare. The largest current company by reported revenue is Medvey Biotech Private Limited at ₹1.68 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medvey Biotech Private Limited U24290MH2021PTC357044 | Director | 15 Mar 2021 | 2021 | ₹1.68 Cr (FY 2024) | Active |
 Astragenics Biosciences Private Limited U46497UT2024PTC018035 | Director | 23 Feb 2025 | 2024 | Active |
Board colleagues of Sangita Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sargun Singh | 09107368 | Medvey Biotech Private Limited | Director |
| Avinash Kumar | 10796820 | Astragenics Biosciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangita Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangita Kumari
Sangita Kumari currently holds 2 directorships: Medvey Biotech Private Limited (Director, since 15 Mar 2021, revenue ₹1.68 Cr (FY 2024)); Astragenics Biosciences Private Limited (Director, since 23 Feb 2025).
Sangita Kumari was first appointed on 15 Mar 2021 as Director at Medvey Biotech Private Limited. The most recent appointment on record is 23 Feb 2025 at Astragenics Biosciences Private Limited.
The current boards of Sangita Kumari's companies include Sargun Singh (Medvey Biotech Private Limited), Avinash Kumar (Astragenics Biosciences Private Limited).